Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov 30:7:549.
doi: 10.3389/fimmu.2016.00549. eCollection 2016.

Molecular and Cellular Characterization of Human CD8 T Suppressor Cells

Affiliations
Review

Molecular and Cellular Characterization of Human CD8 T Suppressor Cells

Zheng Xu et al. Front Immunol. .

Abstract

Bidirectional interactions between dendritic cells and Ag-experienced T cells initiate either a tolerogenic or immunogenic pathway. The outcome of these interactions is of crucial importance in malignancy, transplantation, and autoimmune diseases. Blockade of costimulation results in the induction of T helper cell anergy and subsequent differentiation of antigen-specific CD8+ T suppressor/regulatory cells (Ts). Ts, primed in the presence of inhibitory signals, exert their inhibitory function in an antigen-specific manner, a feature with tremendous clinical potential. In transplantation or autoimmunity, antigen-specific Ts can enforce tolerance to auto- or allo-antigens, while otherwise leaving the immune response to pathogens uninhibited. Alternatively, blockade of inhibitory receptors results in the generation of cytolytic CD8+ T cells, which is vital toward defense against tumors and viral diseases. Because CD8+ T cells are MHC Class I restricted, they are able to recognize HLA-bound antigenic peptides presented not only by APC but also on parenchymal cells, thus eliciting or suppressing auto- or allo-immune reactions.

Keywords: CD8+ T suppressor cells; ILT3; autoimmune disease; co-stimulation blockade; gene profile of CD8+ Ts; transplantation.

PubMed Disclaimer

References

    1. Ohkura N, Sakaguchi S. Regulatory T cells: roles of T cell receptor for their development and function. Semin Immunopathol (2010) 32(2):95–106.10.1007/s00281-010-0200-5 - DOI - PubMed
    1. Josefowicz S, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity (2009) 30(5):616–25.10.1016/j.immuni.2009.04.009 - DOI - PMC - PubMed
    1. Shevach E. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity (2009) 30(5):639–45.10.1016/j.immuni.2009.04.010 - DOI - PubMed
    1. Kuhn A, Beissert S, Krammer PH. CD4 (+) CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res (2009) 301(1):71–81.10.1007/s00403-008-0891-9 - DOI - PubMed
    1. Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, Kadidlo DM, et al. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Transl Med (2011) 3(83):83ra41.10.1126/scitranslmed.3001809 - DOI - PMC - PubMed